Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition

NCT01923558 ↗

Phase 1 Completed 76 enrolled Dr. Reddy's Laboratories Limited

RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate and compare the relative bioavailability and therefore the bioequivalence of two different formulations of donepezil after a single oral dose administration under fasting conditions.

Timeline

Start: 2010-10
Primary completion: 2010-10
Completion: 2010-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	23 mg	Oral

Indications

No indication recorded.